The global corrugated packaging market for pharmaceuticals will grow from USD 9.12 billion in 2025 to USD 16.13 billion by 2034, at a CAGR of 6.54%. The demand for eco-friendly packaging that protects pharmaceutical products for longer is driving this growth. North America leads the market because of its large pharmaceutical companies and strict regulatory rules.
Top Companies in the Corrugated Packaging for Pharmaceutical Market
Latest Announcements by Industry Leaders
- In January 2025, Marlena Hardy, Innovation Product Manager, DS Smith: “TailorTemp® demonstrates just how versatile and reliable fibre-based material can be, not only to maintain temperatures in cold chain logistics, but also to deliver a recyclable outcome for customers seeking to meet sustainability targets. Design is everything, and our team is using specialist predictive modelling in the creation of solutions for our pharma customers that are fit for purpose and then validating them in the laboratory without delay”.
New Advancements in the Market
- In January 2025, DS Smith launches an innovative temperature-controlled packaging solution.
- In October 2024, Berry Global launched a range of clarified polypropylene (PP) bottles for healthcare applications, which offer sustainability and enhanced product protection compared to traditional coloured PET pill bottles.
